Systemic HypertensionSystemic HypertensionСистемные гипертензии2075-082X2542-2189Intermedservice Ltd2906910.26442/SG29069ArticlesСтатьиResearch ArticleThe application of torasemide in patients with arterial hypertension: evidence-based and practical approachesПрименение торасемида у больных артериальной гипертонией: доказательные и практические подходыGilyarevskyS RГиляревскийСергей Руджерович

д-р мед. наук, проф. каф. клин. фармакологии и терапии

sgilarevsky@rambler.ruKuzminaI MКузьминаИрина Михайловна

канд. мед. наук, зав. науч. отд-нием неотложной кардиологии

GolshmidM VГолшмидМария Владимировна

канд. мед. наук, доц. каф. клин. фармакологии и терапии

ГБОУ ДПО РМАПО Минздрава России, МоскваГБУЗ Научно-исследовательский институт скорой помощи им. Н.В.Склифосовского Депарамента здравоохранения г. Москвы15122014114VOL 11, NO4 (2014)ТОМ 11, №4 (2014)798309042020Copyright ©; 2014, Consilium MedicumCopyright ©; 2014, ООО "Консилиум Медикум"2014Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://journals.eco-vector.com/2075-082X/article/view/29069

The article deals with therole of diuretics in treatment of patients suffering from arterial hypertension (AH). We showed evidence-based results of diuretic therapy. We discussed the loop diuretic indications in treatment patients with AH, as well as the possible role of torasemide application in AH patients in certain clinical cases.

В статье обсуждается роль диуретиков при лечении артериальной гипертонии (АГ). Приводятся доказательные основы терапии диуретиками. Рассматриваются показания к применению петлевых диуретиков в лечении АГ, а также возможная роль использования торасемида у больных АГ в определенных клинических ситуациях.

arterial hypertensiondiureticstorasemideартериальная гипертониядиуретикиторасемидДиагностика и лечение артериальной гипертензии (Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов). Системные гипертензии 2010; 3: 5-26.James P.A, Oparil S, Carter B.L et al. 2014 evidence - based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-20.Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-219.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.Carter B.L, Ernst M.E, Cohen J.D. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004; 43: 4-9.Mc Leod P.J, Ogilvie R.I, Ruedy J. Effects of large and small doses of hydrochlorothiazide in hypertensive patients. Clin Pharmacol Ther 1970; 11: 733-9.Freis E.D, Reda D.J, Materson B.J. Volume (weight) loss and blood pressure response following thiazide diuretics. Hypertension 1988; 12: 244-50.Kohvakka A, Salo H, Gordin A, Eisalo A. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene. Acta Med Scand 1986; 219: 381-6.Degnbol B, Dorph S, Marner T. The effect of different diuretics on elevated blood pressure and serum potassium. Acta Med Scand 1973; 193: 407-10.Beermann B, Groschinsky-Grind M. Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug. Eur J Clin Pharmacol 1978; 13: 195-201.Cushman W.C, Khatri I, Materson B.J et al. Treatment of hypertension in the elderly, III: response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs cooperative study. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 1991; 151: 1954-60.Skoularigis J, Strugo V, Chopamba A et al. Low dose hydrochlorothiazide (12,5 to 25 mg daily) as monotherapy in black patients with mild to moderate hypertension: assessment by ambulatory blood pressure monitoring. Am J Hypertens 1995; 8 (pt. 1): 1046-50.Mc Kenney J.M, Goodman R.P, Wright J.T et al. The effect of low - dose hydrochlorothiazide on blood pressure, serum potassium, and lipoproteins. Pharmacotherapy 1986; 6: 179-84.Jounela A.J, Lilja M, Lumme J et al. Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects. Blood Press 1994; 3: 231-5.Levy D, Garrison R.J, Savage D.D et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Intern Med 1989; 110: 101-7.Levy D, Garrison R.J, Savage D.D et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-6.Verdecchia P, Schillaci G, Borgioni C et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48-54.Devereux R.B, Wachtell K, Gerdts E et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292: 2350-6.Long-Ernst M.E, Neaton J.D, Grimm R.H et al. Long - term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension 2011; 58: 1001-7.SDI/Verispan, VONA, Full year 2008. Drug topics. 2010; www.drugtopics.comChobanian A.V, Bakris G.L, Black H.R et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289: 2560-72.Messerli F.H, Makani H, Benjo A et al. Antihypertensive Efficacy of Hydrochlorothiazide as Evaluated by Ambulatory Blood Pressure Monitoring A Meta-Analysis of Randomized Trials. J Am Coll Cardiol 2011; 57: 590-600.Materson B.J, Reda D.J, Cushman W.C et al. Single - drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993; 328: 914-21.Calhoun D.A, Jones D, Textor S et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment. A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51: 1403-19.O'Riordan M. Obesity paradox observed with hydrochlorothiazide, not amlodipine: ACCOMPLISH. 2012; theheart.orgKent S.T, Shimbo D, Huang L et al. Antihypertensive medication classes used among medicare beneficiaries initiating treatment in 2007-2010. PLoS One 2014; 9 (8): e105888. doi: 10.1371/journal.pone.0105888Ernst M.E, Moser M. Use of Diuretics in Patients with Hypertension. N Engl J Med 2009; 361: 2153-64.Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995; 26: 394-400.Dussol B, Moussi-Frances J, Morange S et al. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Nephrol Dial Transplant 2005; 20: 349-53.Sica D.A, Moser M, Black H et al. Diuretic therapy in cardiovascular disease. Hypertension: a companion to Braunwald’s heart disease. Philadelphia: W.B.Saunders, 2007.Paton R.R, Kane R.E. Long - term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharmacol 1977; 17: 243-51.De la Sierra A, Segura J, Banegas J.R et al. Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring. Hypertension 2011; 57: 898-902.Taler S.J, Textor S.C, Augustine J.E. Resistant hypertension: comparing hemody - namic management to specialist care. Hypertension 2002; 39: 982-8.Garg J.P, Elliott W.J, Folker A et al. Resistant hypertension revisited: a comparison of 2 university - based cohorts. Am J Hypertens 2005; 18: 619-26.Vlase H.L, Panagopoulos G, Michelis M.F. Effectiveness of furosemide in uncon - trolled hypertension in the elderly: role of renin profiling. Am J Hypertens 2003; 16: 187-93.Ernst M.E, Carter B.L, Goerdt C.J et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006; 47: 352-8.The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high - risk hypertensive patients randomized to angiotensin - converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990; 82: 1616-28.Sica D.A. Chlorthalidone: has it always been the best thiazide - type diuretic? Hypertension 2006; 47: 321-2.Преображенский Д.В., Сидоренко Б.A., Тарыкина Е.В. и др. Торасемид - петлевой диуретик нового поколения: особенности клинической фармакологии и терапевтическое применение. Кардиология. 2006; 10: 75-86.Achhammer I, Metz P. Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs 1991; 41 (Suppl. 3): 80-91.Puschett J.B, Jordan L.L, Eichelbaum F.M et al. Mode of action of torasemide in man. Prog Pharmacol Clin Pharmacol Stuttgart-New York, 1990; 8 (1): 3-13.Reyes A.J, Chiesa P.D, Santucci M.R et al. Hydrochlorothiazide versus a non - diuretic dose of torasemide as once - daily antihypertensive monopharmacotherapy in elderly patients. A randomized and double - blind study. Eds. F.М.Eichelbaum et al. Prog Pharmacol Clin Pharmacol Stuttgart-New York, 1990; 8 (1): 183-209.Barr W.H, Smith H, Karnes H.T et al. Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers. Eds. F.M.Eichelbaum et al. Prog Pharmacol Clin Pharmacol Stuttgart-New York, 1990; 8 (1): 15-28.Finnerty F.A.Jr, Maxwell M.H, Lunn J, Moser M. Long - term effects of furosemide and hydrochlorothiazide in patients with essential hypertension: a two - year comparison of efficacy and safety. Angiology 1977; 28: 125-33.Uchida T, Yamanaga K, Nishikawa M et al. Anti - aldosteronergic effect of torasemide. Eur J Pharmacol 1991; 26: 145-50.Tsutamoto T, Sakai H, Wada A et al. Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 2004; 44: 2252-3.Tsutamoto T, Wada A, Maeda K et al. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure J Am Coll Cardiol 2000; 36: 838-44.Lopez B, Gonzalez A, Beaumont J et al. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol 2007; 50: 859-67.Franse L.V, Pahor M, Di Bari M et al. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35: 1025-30.Luft F.C. Torasemide in the treatment of arterial hypertension. J Cardiovasc Pharmacol 1993; 22 (Suppl. 3): S32-9.Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther 1993; 7 (Suppl. 1): 63-8.